DGLRX
Price
$22.08
Change
-$0.15 (-0.67%)
Updated
Oct 7 closing price
Net Assets
773.6M
RPEBX
Price
$71.76
Change
-$0.41 (-0.57%)
Updated
Oct 7 closing price
Net Assets
164.4B
Interact to see
Advertisement

DGLRX vs RPEBX

Header iconDGLRX vs RPEBX Comparison
Open Charts DGLRX vs RPEBXBanner chart's image
BNY Mellon Global Stock - I
Price$22.08
Change-$0.15 (-0.67%)
VolumeN/A
Net Assets773.6M
American Funds New Perspective R2E
Price$71.76
Change-$0.41 (-0.57%)
VolumeN/A
Net Assets164.4B
DGLRX vs RPEBX Comparison Chart in %
View a ticker or compare two or three
VS
DGLRX vs. RPEBX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGLRX is a StrongBuy and RPEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 164B vs. DGLRX (774M). DGLRX pays higher dividends than RPEBX: DGLRX (0.41) vs RPEBX (0.12). DGLRX was incepted earlier than RPEBX: DGLRX (19 years) vs RPEBX (11 years). RPEBX (1.21) is less costly to investors than DGLRX (0.91). RPEBX is a more actively managed with annual turnover of: 24.00 vs. DGLRX (10.58). RPEBX has a lower initial minimum investment than DGLRX: RPEBX (250) vs DGLRX (1000). RPEBX annual gain was more profitable for investors over the last year : 13.25 vs. DGLRX (-2.22). RPEBX return over 5 years is better than : 33.50 vs. DGLRX (-8.51).
DGLRXRPEBXDGLRX / RPEBX
Total Expense Ratio0.911.2175%
Annual Report Gross Expense Ratio0.911.2175%
Fund Existence19 years11 years-
Gain YTD7.13318.86738%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets774M164B0%
Annual Yield % from dividends0.410.12348%
Returns for 1 year-2.2213.25-17%
Returns for 3 years10.1261.6816%
Returns for 5 years-8.5133.50-25%
Returns for 10 years20.3692.9022%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTSI6.100.50
+8.93%
VirTra
CORT90.320.47
+0.52%
Corcept Therapeutics
FITBO21.010.05
+0.24%
Fifth Third Bancorp
CSGS63.810.02
+0.03%
CSG Systems International
JBIO9.04-0.10
-1.09%
Jade Biosciences Inc